Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells 12,942 Shares

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 12,942 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $24.81, for a total transaction of $321,091.02. Following the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at $10,218,271.41. This represents a 3.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Omada Health Price Performance

Shares of OMDA stock traded down $0.98 during trading hours on Tuesday, reaching $24.01. The stock had a trading volume of 1,906,414 shares, compared to its average volume of 1,272,868. The firm has a market capitalization of $1.43 billion, a PE ratio of 480.20 and a beta of 1.73. The firm has a 50-day simple moving average of $20.49 and a 200-day simple moving average of $16.26. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.67%. The firm had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. On average, equities analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OMDA has been the subject of a number of recent analyst reports. BTIG Research increased their price objective on Omada Health from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Monday. BMO Capital Markets reiterated an “outperform” rating and set a $24.00 price target on shares of Omada Health in a research report on Friday. Evercore reissued an “outperform” rating and issued a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. Barclays lifted their price objective on shares of Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Friday, May 8th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $25.67.

Institutional Investors Weigh In On Omada Health

Institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in Omada Health during the 2nd quarter valued at $32,000. Bellevue Group AG raised its stake in shares of Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after buying an additional 1,791 shares in the last quarter. Quarry LP acquired a new stake in shares of Omada Health in the fourth quarter valued at $29,000. Barclays PLC boosted its stake in Omada Health by 14.6% during the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after buying an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new position in Omada Health during the fourth quarter worth about $32,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.